Stephane specializes in assessing the impact and opportunities for disruptive technologies, from next-gen "omics" to digital health
David's expertise is in the development of diagnostics strategies and business models for current and emerging diagnostics modalities
Andrew focuses on the adoption and utilization of current and emerging research and diagnostic technologies within biopharma and the clinic
Elle manages all aspects of DeciBio's operations and the execution of DeciBio's growth vision across all departments.
Avoid blind spots in your market. Get the insights you need to accelerate innovation.